Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (1601-1610 of 3,827) with videos related to

Pageof 383
Sort By:
Cancer Cell|September 6, 2007
HIF-dependent antitumorigenic effect of antioxidants in vivoPing Gao, Huafeng Zhang, Ramani Dinavahi, et al.
Cancer Cell|March 3, 2009
p53 and MDM2: antagonists or partners in crime?Christine M Eischen, Guillermina Lozano
Cancer Cell|March 3, 2009
MDM2-dependent downregulation of p21 and hnRNP K provides a switch between apoptosis and growth arrest induced by pharmacologically activated p53Martin Enge, Wenjie Bao, Elisabeth Hedström, et al.
Cancer Cell|March 3, 2009
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesisJohn M L Ebos, Christina R Lee, William Cruz-Munoz, et al.
Cancer Cell|May 30, 2009
Mammary tumorigenesis through LPA receptor signalingJos Jonkers, Wouter H Moolenaar
Cancer Cell|May 30, 2009
Development of androgen receptor antagonists with promising activity in castration-resistant prostate cancerHoward C Shen, Steven P Balk
Cancer Cell|May 30, 2009
Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine modelYuan Wang, Jiong Yang, Huarui Zheng, et al.
Cancer Cell|December 30, 2008
Tumor-associated fibroblasts as "Trojan Horse" mediators of resistance to anti-VEGF therapyGiulio Francia, Urban Emmenegger, Robert S Kerbel
Cancer Cell|December 30, 2008
PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatmentYongping Crawford, Ian Kasman, Lanlan Yu, et al.
Cancer Cell|December 9, 2008
The aneuploidy paradox in cell growth and tumorigenesisBeth A Weaver, Don W Cleveland
Pageof 383

Showing results (1601-1610 of 3,827) with videos related to

Sort By:
Pageof 383
Cancer Cell|September 6, 2007
HIF-dependent antitumorigenic effect of antioxidants in vivoPing Gao, Huafeng Zhang, Ramani Dinavahi, et al.
Cancer Cell|March 3, 2009
p53 and MDM2: antagonists or partners in crime?Christine M Eischen, Guillermina Lozano
Cancer Cell|March 3, 2009
MDM2-dependent downregulation of p21 and hnRNP K provides a switch between apoptosis and growth arrest induced by pharmacologically activated p53Martin Enge, Wenjie Bao, Elisabeth Hedström, et al.
Cancer Cell|March 3, 2009
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesisJohn M L Ebos, Christina R Lee, William Cruz-Munoz, et al.
Cancer Cell|May 30, 2009
Mammary tumorigenesis through LPA receptor signalingJos Jonkers, Wouter H Moolenaar
Cancer Cell|May 30, 2009
Development of androgen receptor antagonists with promising activity in castration-resistant prostate cancerHoward C Shen, Steven P Balk
Cancer Cell|May 30, 2009
Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine modelYuan Wang, Jiong Yang, Huarui Zheng, et al.
Cancer Cell|December 30, 2008
Tumor-associated fibroblasts as "Trojan Horse" mediators of resistance to anti-VEGF therapyGiulio Francia, Urban Emmenegger, Robert S Kerbel
Cancer Cell|December 30, 2008
PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatmentYongping Crawford, Ian Kasman, Lanlan Yu, et al.
Cancer Cell|December 9, 2008
The aneuploidy paradox in cell growth and tumorigenesisBeth A Weaver, Don W Cleveland
Pageof 383